{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:36:27Z","timestamp":1790516187191,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012559","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000}}],"reference-count":60,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012559.pub2","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T08:24:40Z","timestamp":1580199880000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Hormone replacement therapy after surgery for epithelial ovarian cancer"],"prefix":"10.1002","volume":"2020","author":[{"given":"Nungrutai","family":"Saeaib","sequence":"first","affiliation":[{"name":"Prince of Songkla University; Department of Obstetrics and Gynecology, Faculty of Medicine; Hat Yai Songkhla Thailand 90112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krantarat","family":"Peeyananjarassri","sequence":"additional","affiliation":[{"name":"Prince of Songkla University; Department of Obstetrics and Gynecology, Faculty of Medicine; Hat Yai Songkhla Thailand 90112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tippawan","family":"Liabsuetrakul","sequence":"additional","affiliation":[{"name":"Prince of Songkla University; Epidemiology Unit, Faculty of Medicine; Hat Yai Songkhla Thailand 90110"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakchai","family":"Buhachat","sequence":"additional","affiliation":[{"name":"Prince of Songkla University; Department of Obstetrics and Gynecology, Faculty of Medicine; Hat Yai Songkhla Thailand 90112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Myriokefalitaki","sequence":"additional","affiliation":[{"name":"The Christie NHS Foundation Trust; Gynaecological Oncology; Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"issue":"35","key":"10.1002\/14651858.CD012559.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1200\/JCO.2015.60.9719","article-title":"Adjuvant hormone therapy may improve survival in epithelial ovarian cancer: results of the AHT Randomized Trial","volume":"33","author":"Eeles","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD012559.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1013::AID-CNCR17>3.0.CO;2-1","article-title":"Estrogen replacement therapy for ovarian carcinoma survivors: a randomized controlled trial","volume":"86","author":"Guidozzi","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD012559.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3892\/ol.2011.461","article-title":"Impact of post-operative hormone replacement therapy on life quality and prognosis in patients with ovarian malignancy","volume":"3","author":"Li","year":"2012","journal-title":"Oncology Letters"},{"issue":"13","key":"10.1002\/14651858.CD012559.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial","volume":"290","author":"Anderson","year":"2003","journal-title":"Journal of the American Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD012559.pub2-BIB0005|cit5","first-page":"192","article-title":"Hormone replacement therapy after epithelial ovarian cancer treatment","volume":"21","author":"Bebar","year":"2000","journal-title":"European Journal of Gynaecological Oncology"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0006|cit6","unstructured":"Guidozzi F Hormone replacement therapy in patients with ovarian cancer The 29th Congress of the South African Society of Obstetrics and Gynecology XAOC - LTE 1998; 29-XPH - N1998"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0007|cit7","first-page":"Abstract A13","article-title":"Estrogen replacement therapy in ovarian cancer survivors","volume":"9 Suppl 1 XPH -","author":"Guidozzi","year":"1999","journal-title":"International journal of gynecological cancer"},{"issue":"6","key":"10.1002\/14651858.CD012559.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/13697137.2013.806471","article-title":"Estrogen therapy in gynecological cancer survivors","volume":"16","author":"Guidozzi","year":"2013","journal-title":"Climacteric"},{"issue":"11","key":"10.1002\/14651858.CD012559.pub2-BIB0009|cit9","first-page":"843","article-title":"Relationship between hormone therapy in women with ovarian malignancy and prognosis","volume":"43","author":"Li","year":"2008","journal-title":"Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics & Gynecology]"},{"issue":"35","key":"10.1002\/14651858.CD012559.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1200\/JCO.2015.63.6670","article-title":"To treat or not to treat: the use of hormone replacement therapy in patients with ovarian cancer","volume":"33","author":"Lipkowitz","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012559.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00042192-200101000-00012","article-title":"Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival","volume":"8","author":"Ursic-Vrscaj","year":"2001","journal-title":"Menopause"},{"issue":"11","key":"10.1002\/14651858.CD012559.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1210\/jc.2015-2238","article-title":"Menopausal hormone therapy and mortality: a systematic review and meta-analysis","volume":"100","author":"Benkhadra","year":"2015","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD012559.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.maturitas.2015.07.006","article-title":"Treatment of climacteric symptoms in survivors of gynaecological cancer","volume":"82","author":"Biglia","year":"2015","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/01443615.2012.668579","article-title":"Safety of hormone replacement therapy in gynaecological cancer survivors","volume":"32","author":"Biliatis","year":"2012","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies","volume":"385","author":"Collaborative Group on Epidemiological Studies of Ovarian Cancer","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD012559.pub2-BIB0016|cit16","first-page":"296","article-title":"Breast cancer after use of estrogen plus progestin and estrogen alone; analyses of data from 2 Women's Health Initiative randomized clinical trials","volume":"1","author":"Chlebowski","year":"2015","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0017|cit17","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"2","key":"10.1002\/14651858.CD012559.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JME-14-0252","article-title":"Progesterone action in breast, uterine, and ovarian cancers","volume":"54","author":"Diep","year":"2015","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bmj.302.6771.259","article-title":"Hormone replacement therapy and survival after surgery for ovarian cancer","volume":"302","author":"Eeles","year":"1991","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0021|cit21","first-page":"757","article-title":"Epithelial ovarian cancer","volume-title":"Principles and Practice of Gynecologic Oncology","author":"Fleming","year":"2013"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0022|cit22","unstructured":"International Agency for Research on Cancer and World Health Organization Cancer Today. Estimated age-standardized incidence rates (World) in 2018, worldwide, both sexes, all ages Available from https:\/\/gco.iarc.fr\/today"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"357","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0024|cit24","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD012559.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ygyno.2003.11.044","article-title":"Ovarian cancer patients and hormone replacement therapy: a systematic review","volume":"92","author":"Hopkins","year":"2004","journal-title":"Gynecologic Oncology"},{"issue":"24","key":"10.1002\/14651858.CD012559.pub2-BIB0026|cit26","first-page":"1","article-title":"Mechanisms for estrogen receptor expression in human cancer","volume":"7","author":"Hua","year":"2018","journal-title":"Experimental Hematology & Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012559.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ygyno.2011.03.012","article-title":"Hormone replacement therapy in gynecologic cancer survivors: why not?","volume":"122","author":"Ibeanu","year":"2011","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012559.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5001\/omj.2015.34","article-title":"Assessment of questionnaire measuring quality of life in menopausal women: a systematic review","volume":"30","author":"Jenabi","year":"2015","journal-title":"Oman Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD012559.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/2046-4053-2-81","article-title":"Assessing and presenting summaries of evidence in Cochrane Reviews","volume":"23","author":"Langendam","year":"2013","journal-title":"Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012559.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012559.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.maturitas.2013.04.003","article-title":"Age at natural menopause in relation to all-cause and cause-specific mortality in a follow-up study of U.S. black women","volume":"75","author":"Li","year":"2013","journal-title":"Maturitas"},{"issue":"2","key":"10.1002\/14651858.CD012559.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2015.07.109","article-title":"Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis","volume":"139","author":"Li","year":"2015","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012559.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2013.03.026","article-title":"An international assessment of ovarian cancer incidence and mortality","volume":"130","author":"Lowe","year":"2013","journal-title":"Gynecologic Oncology"},{"issue":"22","key":"10.1002\/14651858.CD012559.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"36845","DOI":"10.18632\/oncotarget.15982","article-title":"Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis","volume":"8","author":"Luo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"100955","DOI":"10.1016\/j.pmedr.2019.100955","article-title":"The association of age at menopause and all-cause and cause-specific mortality by race, postmenopausal hormone use, and smoking status","volume":"15","author":"Malek","year":"2019","journal-title":"Preventive Medicine Reports"},{"issue":"13","key":"10.1002\/14651858.CD012559.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"Journal of the American Medical Association"},{"issue":"7","key":"10.1002\/14651858.CD012559.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/GME.0000000000000126","article-title":"Hormone therapy in oophorectomized BRCA 1\/2 mutation carriers","volume":"21","author":"Marchetti","year":"2013","journal-title":"Menopause"},{"issue":"7","key":"10.1002\/14651858.CD012559.pub2-BIB0039|cit39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004143.pub4","article-title":"Long term hormone therapy for perimenopausal and postmenopausal women","author":"Marjoribanks","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012559.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1002\/ijc.22218","article-title":"Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival","volume":"119","author":"Mascarenhas","year":"2006","journal-title":"International Journal of Cancer"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/2046-4053-3-82","article-title":"A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation","volume":"3","author":"Meader","year":"2014","journal-title":"Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012559.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/CCO.0b013e32832efc5b","article-title":"Managing menopausal symptoms after gynecological cancer","volume":"21","author":"Michaelson-Cohen","year":"2009","journal-title":"Current Opinion in Oncology"},{"issue":"7","key":"10.1002\/14651858.CD012559.pub2-BIB0043|cit43","first-page":"767","article-title":"Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis","volume":"1","author":"Muka","year":"2016","journal-title":"Journal of the American Medical Association"},{"issue":"12","key":"10.1002\/14651858.CD012559.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/aje\/kwr446","article-title":"Hormone therapy and different ovarian cancers: a National Cohort Study","volume":"175","author":"M\u00f8rch","year":"2012","journal-title":"American Journal of Epidemiology"},{"issue":"24","key":"10.1002\/14651858.CD012559.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012559.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/GME.0000000000000508","article-title":"Hormone therapy for ovarian cancer survivors: systematic review and meta-analysis","volume":"23","author":"Pergialiotis","year":"2015","journal-title":"Menopuase"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0047|cit47","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"11","key":"10.1002\/14651858.CD012559.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.285.11.1460","article-title":"Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women","volume":"285","author":"Rodriguez","year":"2001","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"10.1002\/14651858.CD012559.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"Journal of the American Medical Association"},{"issue":"13","key":"10.1002\/14651858.CD012559.pub2-BIB0050|cit50","first-page":"1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0051|cit51","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glaziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org\/handbook"},{"issue":"37","key":"10.1002\/14651858.CD012559.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"62400","DOI":"10.18632\/oncotarget.18253","article-title":"Correlation between estrogen receptor expression and prognosisin epithelial ovarian cancer: a meta-analysis","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1002\/14651858.CD012559.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/GME.0000000000000550","article-title":"Hormone therapy and risk of ovarian cancer in postmenopausal women: a systematic review and meta-analysis","volume":"23","author":"Shi","year":"2015","journal-title":"Menopause"},{"issue":"3","key":"10.1002\/14651858.CD012559.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.maturitas.2009.11.017","article-title":"Hormone replacement after gynaecological cancer","volume":"65","author":"Singh","year":"2010","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s11136-013-0387-8","article-title":"Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attention","volume":"22","author":"Snyder","year":"2013","journal-title":"Quality of Life Research"},{"key":"10.1002\/14651858.CD012559.pub2-BIB0056|cit56","first-page":"1","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"BioMed Central"},{"issue":"6","key":"10.1002\/14651858.CD012559.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3109\/13697137.2013.806472","article-title":"The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China","volume":"16","author":"Wen","year":"2013","journal-title":"Climacteric"},{"issue":"1","key":"10.1002\/14651858.CD012559.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/IGC.0b013e3182788466","article-title":"Prognostic role of hormone receptors in ovarian cancer: a systematic review and meta-analysis","volume":"23","author":"Zhao","year":"2013","journal-title":"International Journal of Gynecological Cancer"},{"issue":"1","key":"10.1002\/14651858.CD012559.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1078-0432.CCR-14-1816","article-title":"Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis","volume":"21","author":"Zhong","year":"2015","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1002\/14651858.CD012559.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ygyno.2007.12.003","article-title":"Hormone replacement therapy and ovarian cancer risk: a meta-analysis","volume":"108","author":"Zhou","year":"2008","journal-title":"Gynecologic Oncology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012559.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T09:03:17Z","timestamp":1664182997000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012559.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012559.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]}}}